Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11958891 Tissue-specific Wnt signal enhancing molecules and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yang Li0

Zhengjian Zhang0

Aaron Ken Sato0

Teppei Yamaguchi0

Jennifer Jean Brady0

Wen-Chen Yeh0

Date of Patent

April 16, 2024

0

Patent Application Number

164810010

Date Filed

January 26, 2018

0

Patent Citations

US Patent 8691966 RNA containing modified nucleosides and methods of use thereof

0

US Patent 8748089 RNA containing modified nucleosides and methods of use thereof

0

US Patent 8835108 RNA containing modified nucleosides and methods of use thereof

0

US Patent 9296826 Antibodies and methods for WNT pathway-related diseases

0

US Patent 8969526 Antibody Fc variants

0

US Patent 9771427 ASGPR antibodies and uses thereof

0

US Patent 8278036 RNA containing modified nucleosides and methods of use thereof

0

US Patent 8507442 Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8

0

Patent Primary Examiner

Christine J. Saoud

0

Patent abstract

The present disclosure provides tissue-specific Wnt signal enhancing molecules, and related methods of using these molecules to increase Wnt signaling in targeted tissues.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11958891 Tissue-specific Wnt signal enhancing molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool